Role of cysteine residues of p65/NF-κB on the inhibition by the sesquiterpene lactone parthenolide and N-ethyl maleimide, and on its transactivating potential

Life Sciences

Volumn 75, Issue 7, 2004, Pages 841-856

  Garcia Pineres A J ^a   Lindenmeyer, M T ^a   Merfort, I ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Cysteine 38; Different cell lines; I B; N ethyl maleimide; NF B; p50; p65; Parthenolide; Sesquiterpene lactones; Transactivating potential

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; N ETHYLMALEIMIDE; PARTHENOLIDE; SYNAPTOTAGMIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA ANALYSIS; DNA BINDING; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME REGULATION; GENE MUTATION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CALCIUM-BINDING PROTEINS; CYSTEINE; DNA-BINDING PROTEINS; ETHYLMALEIMIDE; HELA CELLS; HUMANS; I-KAPPA B KINASE; JURKAT CELLS; MACROPHAGES; MEMBRANE GLYCOPROTEINS; MICE; MUTATION; NERVE TISSUE PROTEINS; NF-KAPPA B; PROTEIN-SERINE-THREONINE KINASES; SESQUITERPENES; SYNAPTOTAGMIN I; SYNAPTOTAGMINS; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTOR RELA; TRANSFECTION;

EID: 2942618506     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2004.01.024     Document Type: Article

References (43)

1. Baeuerle P.A., Baltimore D. Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NF-kappa B transcription factor. Cell. 53:1988;211-217
2. Cernuda-Morollon E., Pineda-Molina E., Canada F.J., Perez-Sala D. 15-Deoxy-delta 12, 14-prostaglandin J2 inhibition of NF-kappaB-DNA binding through covalent modification of the p50 subunit. Journal of Biological Chemistry. 276:2001;35530-35536
3. Chen F., Castranova V., Shi X., Demers L.M. New insights into the role of nuclear factor-kappaB, a ubiquitous transcription factor in the initiation of diseases. Clinical Chemistry. 45:1999;7-17
4. Chen F.E., Huang D.B., Chen Y.Q., Ghosh G. Crystal structure of p50/p65 heterodimer of transcription factor NF-kappaB bound to DNA. Nature. 391:1998;410-413
5. Dvir A. Promoter escape by RNA polymerase II. Biochimica Biophysica Acta. 1577:2002;208
6. García-Piñeres A.J., Castro V., Mora G., Schmidt T.J., Strunck E., Pahl H.L., Merfort I. Cysteine 38 in p65/NF-kappaB plays a crucial role in DNA binding inhibition by sesquiterpene lactones. Journal of Biological Chemistry. 276:2001;39713-39720
7. Glineur C., Davioud-Charvet E., Vandenbunder B. The conserved redox-sensitive cysteine residue of the DNA-binding region in the c-Rel protein is involved in the regulation of the phosphorylation of the protein. Biochemical Journal. 352(Pt 2):2000;583-591
8. Graham F.L., Smiley J., Russell W.C., Nairn R. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. Journal of General Virology. 36:1977;59-74
9. Hehner S.P., Heinrich M., Bork P.M., Vogt M., Ratter F., Lehmann V., Schulze-Osthoff K., Dröge W., Schmitz M.L. Sesquiterpene lactones specifically inhibit activation of NF-kappa B by preventing the degradation of I kappa B-alpha and I kappa B-beta. Journal of Biological Chemistry. 273:1998;1288-1297
10. Hehner S.P., Hofmann T.G., Dröge W., Schmitz M.L. The antiinflammatory sesquiterpene lactone parthenolide inhibits NF-kappa B by targeting the I kappa B kinase complex. Journal of Immunology. 163:1999;5617-5623
11. Henkel T., Machleidt T., Alkalay I., Kronke M., Ben Neriah Y., Baeuerle P.A. Rapid proteolysis of I kappa B-alpha is necessary for activation of transcription factor NF-kappa B. Nature. 365:1993;182-185
12. Heptinstall S., Awang D.V.C. Feverfew: A Review of its History, its Biological and Medicinal Properties, and the Status of Commercial Preparations of the Herb. Lawson L.D., Bauer R. Phytomedicines of Europe: Chemistry and Biological Activity. 1998;158-175 American Chemical Society, Washington, DC
13. Hsu L. Promoter clearance and escape in prokaryotes. Biochimica Biophysica Acta. 1577:2002;191
14. Jones H.W. Jr., McKusick V.A., Harper P.S., Wuu K.D. George Otto Gey. (1899-1970). The HeLa cell and a reappraisal of its origin. Obstretrics & Gynecology. 38:1971;945-949
15. Karin M., Lin A. NF-kappaB at the crossroads of life and death. Nature Immunology. 3:2002;221-227
16. Karin M., Ben Neriah Y. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annual Reviews of Immunology. 18:2000;621-663
17. Karin M., Delhase M. The I kappa B kinase (IKK) and NF-kappa B: key elements of proinflammatory signalling. Seminars in Immunology. 12:2000;85-98
18. Kieran M., Blank V., Logeat F., Vandekerckhove J., Lottspeich F., Le Bail O., Urban M.B., Kourilsky P., Baeuerle P.A., Israel A. The DNA binding subunit of NF-kappa B is identical to factor KBF1 and homologous to the rel oncogene product. Cell. 62:1990;1007-1018
19. Kumar S., Rabson A.B., Gelinas C. The RxxRxRxxC motif conserved in all Rel/kappa B proteins is essential for the DNA-binding activity and redox regulation of the v-Rel oncoprotein. Molecular and Cellular Biology. 12:1992;3094-3106
20. Kwok B.H., Koh B., Ndubuisi M.I., Elofsson M., Crews C.M. The anti-inflammatory natural product parthenolide from the medicinal herb feverfew directly binds to and inhibits IkappaB kinase. Chemistry and Biology. 8:2001;759-766
21. Lee J.H., Koo T.H., Hwang B.Y., Lee J.J. Kaurane diterpene, kamebakaurin, inhibits NF-kappa B by directly targeting the DNA-binding activity of p50 and blocks the expression of antiapoptotic NF-kappa B target genes. Journal of Biological Chemistry. 277:2002;18411-18420
22. Lyß G., Schmidt T.J., Merfort I., Pahl H.L. Helenalin, an anti-inflammatory sesquiterpene lactone from Arnica, selectively inhibits transcription factor NF-kappaB. Biological Chemistry. 378:1997;951-961
23. Lyß G., Knorre A., Schmidt T.J., Pahl H.L., Merfort I. The anti-inflammatory sesquiterpene lactone helenalin inhibits the transcription factor NF-kappaB by directly targeting p65. Journal of Biological Chemistry. 273:1998;33508-33516
24. Mahon T.M., O'Neill L.A. Studies into the effect of the tyrosine kinase inhibitor herbimycin A on NF-kappa B activation in T lymphocytes. Evidence for covalent modification of the p50 subunit. Journal of Biological Chemistry. 270:1995;28557-28564
25. Marshall H.E., Stamler J.S. Inhibition of NF-kappa B by S-nitrosylation. Biochemistry. 40:2001;1688-1693
26. Mazor R.L., Menendez I.Y., Ryan M.A., Fiedler M.A., Wong H.R. Sesquiterpene lactones are potent inhibitors of interleukin 8 gene expression in cultured human respiratory epithelium. Cytokine. 12:2000;239-245
27. Matthews J.R., Wakasugi N., Virelizier J.L., Yodoi J., Hay R.T. Thioredoxin regulates the DNA binding activity of NF-kappa B by reduction of a disulphide bond involving cysteine 62. Nucleic Acids Research. 20:1992;3821-3830
28. Pahl H.L. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene. 18:1999;6853-6866
29. Picman A.K., Rodriguez E., Towers G.H. Formation of adducts of parthenin and related sesquiterpene lactones with cysteine and glutathione. Chemico-Biological Interactions. 28:1979;83-89
30. Pineda-Molina E., Klatt P., Vazquez J., Marina A., Garcia D.L., Perez-Sala D., Lamas S. Glutathionylation of the p50 subunit of NF-kappaB: a mechanism for redox-induced inhibition of DNA binding. Biochemistry. 40:2001;14134-14142
31. Ralph P., Nakoinz I. Antibody-dependent killing of erythrocyte and tumor targets by macrophage-related cell lines: enhancement by PPD and LPS. Journal of Immunology. 119:1977;950-954
32. Rossi A., Kapahi P., Natoli G., Takahashi T., Chen Y., Karin M., Santoro M.G. Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase. Nature. 403:2000;103-108
33. Ruben S.M., Dillon P.J., Schreck R., Henkel T., Chen C.H., Maher M., Baeuerle P.A., Rosen C.A. Isolation of a rel-related human cDNA that potentially encodes the 65-kD subunit of NF-kappa B. Science. 251:1991;1490-1493
34. Rüngeler P., Castro V., Mora G., Gören N., Vichnewski W., Pahl H.L., Merfort I., Schmidt T.J. Inhibition of transcription factor NF-kappaB by sesquiterpene lactones: a proposed molecular mechanism of action. Bioorganic & Medicinal Chemistry. 7:1999;2343-2352
35. Schmidt T.J. Helenanolide-type sesquiterpene lactones-III. Rates and stereochemistry in the reaction of helenalin and related helenanolides with sulfhydryl containing biomolecules. Bioorganic & Medicinal Chemistry. 5:1997;645-653
36. Schmitz M.L., Bacher S., Kracht M. I kappa B-independent control of NF-kappa B activity by modulatory phosphorylations. Trends in Biochemical Science. 26:2001;186-190
37. Schmitz M.L., Baeuerle P.A. The p65 subunit is responsible for the strong transcription activating potential of NF-kappa B. EMBO J. 10:1991;3805-3817
38. Schneider U., Schwenk H.U., Bornkamm G. Characterization of EBV-genome negative "null" and "T" cell lines derived from children with acute lymphoblastic leukemia and leukemic transformed non-Hodgkin lymphoma. International Journal of Cancer. 19:1977;621-626
39. Straus D.S., Pascual G., Li M., Welch J.S., Ricote M., Hsiang C.H., Sengchanthalangsy L.L., Ghosh G., Glass C.K. 15-deoxy-delta 12, 14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway. Proceedings of the National Academy of Sciences U.S.A. 97:2000;4844-4849
40. Tak P.P., Firestein G.S. NF-kappaB: a key role in inflammatory diseases. Jornal of Clinical Investigation. 107:2001;7-11
41. Urban M.B., Baeuerle P.A. The role of the p50 and p65 subunits of NF-kappa B in the recognition of cognate sequences. New Biology. 3:1991;279-288
42. Willuhn G. Arnica Folwers: Pharmacology, Toxicology, and Analysis of the Sesquiterpene Lactones - Their Main Active Substances. Lawson L.D., Bauer R. Phytomedicines of Europe: Chemistry and Biological Activity. 1998;118-132 American Chemical Society, Washington, DC
43. Yamamoto Y., Gaynor R.B. Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer. Jornal of Clinical Investigation. 107:2001;135-142